Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Public ClinicalTrials.gov record NCT07210515. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Triple-blind, Placebo-controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Intravenous AMBTX-01 (Neridronate) for Treatment of Complex Regional Pain Syndrome Type 1 (CRPS-RISE)
Study identification
- NCT ID
- NCT07210515
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Ambros Therapeutics, Inc.
- Industry
- Enrollment
- 270 participants
Conditions and interventions
Conditions
Interventions
- Neridronate Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 13, 2026
- Primary completion
- Nov 30, 2027
- Completion
- Dec 31, 2027
- Last update posted
- May 13, 2026
2026 – 2028
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ambros Clinical Trial Site | Phoenix | Arizona | 85032 | Recruiting |
| Ambros Clinical Trial Site | Tucson | Arizona | 85710 | Recruiting |
| Ambros Clinical Trial Site | Tustin | California | 92780 | Recruiting |
| Ambros Clinical Trial Site | Brandon | Florida | 33511 | Recruiting |
| Ambros Clinical Trial Site | Pembroke Pines | Florida | 33025 | Recruiting |
| Ambros Clinical Trial Site | Newnan | Georgia | 30265 | Recruiting |
| Ambros Clinical Trial Site | Winston-Salem | North Carolina | 27103 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07210515, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07210515 live on ClinicalTrials.gov.